Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study

Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
Journal of Nuclear Medicine September 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
Caroline Bodet-Milin
1Université de Nantes, CHU Nantes, CNRS, INSERM, CRCINA, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Faivre-Chauvet
1Université de Nantes, CHU Nantes, CNRS, INSERM, CRCINA, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Carlier
1Université de Nantes, CHU Nantes, CNRS, INSERM, CRCINA, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Ansquer
1Université de Nantes, CHU Nantes, CNRS, INSERM, CRCINA, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurore Rauscher
2Pharmacy Unit, ICO Cancer Center, Saint-Herblain, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Frampas
1Université de Nantes, CHU Nantes, CNRS, INSERM, CRCINA, Nantes, France;
2Pharmacy Unit, ICO Cancer Center, Saint-Herblain, France;
3Radiology Department, University Hospital, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederique Toulgoat
3Radiology Department, University Hospital, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damien Masson
4Biology Department, University Hospital, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mickael Bourgeois
1Université de Nantes, CHU Nantes, CNRS, INSERM, CRCINA, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evelyne Cerato
5Délégation à la Recherche Clinique et à l’Innovation, University Hospital, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Rohmer
6Endocrinology Department, University Hospital, Angers, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Couturier
7Nuclear Medicine Department, University Hospital, Angers, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delphine Drui
8Endocrinology Department, University Hospital, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Goldenberg
9IBC Pharmaceuticals, Inc., Morris Plains, New Jersey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert M. Sharkey
10Immunomedics, Inc., Morris Plains, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Barbet
11GIP Arronax, Saint-Herblain, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francoise Kraeber-Bodere
1Université de Nantes, CHU Nantes, CNRS, INSERM, CRCINA, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (9)
Journal of Nuclear Medicine
Vol. 62, Issue 9
September 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet, Francoise Kraeber-Bodere
Journal of Nuclear Medicine Sep 2021, 62 (9) 1221-1227; DOI: 10.2967/jnumed.120.252791

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet, Francoise Kraeber-Bodere
Journal of Nuclear Medicine Sep 2021, 62 (9) 1221-1227; DOI: 10.2967/jnumed.120.252791
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology

  • Radioimmunotherapy in Oncology
  • The Role of NAC FDG-PET/CT in Detecting Cutaneous Lesions
  • Quantitative assessment of radiation therapy-induced cardiovascular complications with FDG-PET and NaF-PET imaging in lung cancer and other thoracic malignancies
Show more Oncology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • immuno-PET
  • MTC
  • carcinoembryonic antigen
  • bispecific antibody
  • pretargeted radioimmunoimaging
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire